Synergy for staphylococcal endocarditis

Synergy for staphylococcal endocarditis refers to the adjunctive therapeutic strategy employed in the management of severe cardiovascular infections caused by *Staphylococcus* species, most notably *Staphylococcus aureus* and coagulase-negative staphylococci affecting native or prosthetic heart valves and intracardiac devices The synergistic approach combines a primary cell-wall-active antimicrobial or biofilm-penetrating agent with a secondary bactericidal agent, specifically to enhance bacteri...

Synergy for staphylococcal endocarditis refers to the adjunctive therapeutic strategy employed in the management of severe cardiovascular infections caused by *Staphylococcus* species, most notably *Staphylococcus aureus* and coagulase-negative staphylococci affecting native or prosthetic heart valves and intracardiac devices The synergistic approach combines a primary cell-wall-active antimicrobial or biofilm-penetrating agent with a secondary bactericidal agent, specifically to enhance bacteri...

In this clinical state, the endocardium develops infected thrombotic vegetations that harbor high bacterial densities, frequently complicated by tissue destruction, systemic embolization, and refractory bacteremia

In this clinical state, the endocardium develops infected thrombotic vegetations that harbor high bacterial densities, frequently complicated by tissue destruction, systemic embolization, and refractory bacteremia